ANGIODYNAMICS INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - April 9, 2012

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR2.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR10.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR16.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR14.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR13.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR15.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR19.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR11.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR12.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR4.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR18.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR1.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR17.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR3.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR7.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR6.htm
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR8.htm
EXCEL - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - ANGIODYNAMICS INCR9.htm
EX-32.2 - CERTIFICATION PURSUANT TO SECTION 906 - ANGIODYNAMICS INCd323745dex322.htm
EX-32.1 - CERTIFICATION PURSUANT TO SECTION 906 - ANGIODYNAMICS INCd323745dex321.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - ANGIODYNAMICS INCd323745dex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - ANGIODYNAMICS INCd323745dex311.htm
10-Q - FORM 10-Q - ANGIODYNAMICS INCd323745d10q.htm
v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Feb. 29, 2012
Feb. 28, 2011
Cash flows from operating activities:    
Net income $ 1,934 $ 8,978
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 9,461 9,112
Amortization of bond discounts and premiums 501  
Tax effect on exercise of stock options and issuance of performance shares (237) (97)
Deferred income taxes (247) 2,437
Stock based compensation 2,998 3,402
Change in accounts receivable allowances 46 (63)
Other (224) (29)
Changes in operating assets and liabilities:    
Accounts receivable 372 1,440
Inventories (277) 55
Prepaid expenses and other (5,282) 2,371
Accounts payable and accrued liabilities 3,457 (5,633)
Net cash provided by operating activities 12,502 21,973
Cash flows from investing activities:    
Additions to property, plant and equipment (1,879) (1,972)
Acquisition of intangible and other assets (500) (1,084)
Other cash flows from investing activities 1,000 (182)
Purchases of marketable securities (118,323) (149,990)
Proceeds from sale or maturity of marketable securities 94,262 105,890
Net cash used in investing activities (25,440) (47,338)
Cash flows from financing activities:    
Repayment of long-term debt (205) (195)
Proceeds from exercise of stock options and employee stock purchase plan 3,312 2,012
Repurchase and retirement of shares (2,104)  
Net cash provided by financing activities 1,003 1,817
Effect of exchange rate changes on cash and cash equivalents (2) 42
Decrease in cash and cash equivalents (11,937) (23,506)
Cash and cash equivalents at beginning of period 45,984 58,763
Cash and cash equivalents at end of period $ 34,047 $ 35,257

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by ANGIODYNAMICS INC and has no official or unofficial affiliation with ANGIODYNAMICS INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.